U.S. pharma big copyright scrapped two experimental weight loss pills previous calendar year—a when-every day capsule, lotiglipron, due to elevated liver enzymes along with a two times-daily pill, danuglipron, because of powerful Unintended effects—but CEO Albert Bourla has claimed t